{"brief_title": "Vaccine Therapy for Patients With Stage III Melanoma", "brief_summary": "This is a Phase 3 study in patients with melanoma that has spread to the lymph nodes (stage III), and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax\u2122 vaccine to prevent or slow the recurrence of melanoma.", "condition": "Malignant Melanoma", "intervention_type": "Biological", "intervention_name": "CancerVax vaccine (CANVAXIN)", "criteria": "- Must have Stage III melanoma - Must have had all clinically-detectable disease surgically removed - Cannot be taking any medications, or undergoing any therapies which compromise the functioning of your immune system (ie. Some corticosteroids, and certain types of radiation therapy) - Cannot have HIV or Hepatitis A, B, or C", "gender": "All", "minimum_age": "18 Years", "maximum_age": "80 Years", "healthy_volunteers": "No", "id": "NCT00052130.xml"}